C
COCP
Cocrystal Pharma Inc
1.140
+0.020+1.79%After Hours: 1.171 +0.031 +2.73%17:15 08/27 EDT
OPEN/PREV CLOSE1.100/1.120
TODAY RANGE1.100-1.170
VOL44.94K
MARKET CAP21.96M
52 WEEK RANGE0.7600-2.670
AVG VOL (3M)72.22K
% TURNOVER0.23%
TURNOVER--
P/E (TTM)-1.5034
% RANGE6.25%
EPS(TTM)-0.7583
P/E(FORWARD)-1.6522
P/B15.06
BVPS0.0757
DIVIDEND--
P/S70.14
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.53M
SHARES OUTSTANDING19.26M
NEXT EARNINGS11/12-11/16
FREE FLOAT6.60M
LOT SIZE1
EX-DATE10/11/2022
News
Press Releases
Financial Reports
Profile
TipRanks·08/18 21:00
Cocrystal Pharma Adds Veteran Leader to Board of Directors
TipRanks·08/17 20:52
Cocrystal Pharma strengthens board with antiviral expert appointment
Dow Jones·08/17 15:18
*Cocrystal Pharma Appoints Carol Brosgart, MD to Its Bd of Directors
Benzinga·08/13 12:23
Cocrystal Pharma Q2 EPS $(0.23) Misses $(0.17) Estimate, Sales $105.000K
TipRanks·08/06 02:07
Top Insider Makes Bold New Move on Cocrystal Pharma Stock
TipRanks·08/03 11:48
OPKO Health Boosts Stake in Cocrystal Pharma Financing
TipRanks·08/03 11:25
Cocrystal Pharma announces $5M investment from Opko Health
TipRanks·07/17 12:28
Cocrystal Pharma Shareholders Approve Governance and Oversight Measures
TipRanks·06/09 11:31
Cocrystal Pharma Appoints New CEO to Lead Transition
TipRanks·06/03 13:58
Cocrystal Pharma Names New CEO to Drive Antiviral Pipeline
NASDAQ·06/03 12:22
Cocrystal Pharma Names James Sapirstein CEO, Stock Up In Pre-market
TipRanks·06/03 11:14
Cocrystal co-CEOs Sam Lee and Jim Martin step down, James Sapirstein succeeds
Dow Jones·06/03 11:02
*Cocrystal Pharma: Lee to Continue as Pres and Transition to Scientific Chief
Dow Jones·06/03 11:02
*Cocrystal Pharma: Martin to Continue as Financial Chief
Same Industry
Name/Symbol
Change%
Price